US4558690A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of administration of chemotherapy to tumors
Assignee: SCRANTON AN INSTITUTION OF HIGHER EDUCATION OF, University of
•
Filing: 1982-01-26
•
Granted: 1985-12-17
•
Expires: 2002-01-26
Abstract
Abstract An improved method of administration of microspheres of cytotoxic chemicals to tumor sites without effect on non tumor tissue is disclosed. The method comprises injection of chemotherapeutic agents coated with a thermoplastic polymer having a melting point above normal body temperature (in a melting point range of about 40°-46° C.) accompanied by dielectric radio-frequency localized heating of the tumor to elevate its interior temperature above the melting point of the encapsulating thermoplastic polymer. The tumor is partially necrosed and sensitized by the R.F. nonionizing radiation bombardment and the entry of the chemotherapy agent triggered by the removal of the protective coat of thermoplastic polymer. A preferred embodiment of the invention is a dose of 30 mg of methotrexate (A-methopterin) in the form of spherical microscapsules having an average of 200-800 microns diameter and a polymer of polystearyl acrylate encapsulating coating of an average thickness of 1-50 microns. This dose is injected into the tumor and released by a 30-60 minute irradiation of the tumor by 175-200 watts of R.F. non-ionizing radiation at a frequency of 13.56 megahertz from a set of capacitive plates positioned on opposite sides of the impregnated tumors. The tumor temperature is elevated to a threshold temperature of 43° C. which is the melting point and release point of the encapsulated acrylic resin. The temperature of the rest of the organism outside the tumor remains at 39°-40° C. which is below the release temperature of the resin.
Inventors
- 👤 Patrick J. Joyce
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 13:05
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0002; A61K9/0009; A61F; A61F7/00; A61K9/14; A61K9/16; A61K9/1605; A61K9/1629; A61K9/1635; A61F2007/0089
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
128 words
A method for treatment of tumors of animals and humans which comprises: (a) elevating the temperature of the tumor with exposure to a nonionizing radiofrequency field to partially necrose and attenuate its cells, (b) injecting intratumorally and extracellularly into the tumor interstices a therapeutic dose of a tumoricidal agent encapsulated with a polymeric coating of a biologically inert thermoplastic resin characterized as having a melting point higher than the temperature of the surrounding body tissue and within the elevated temperature range of the tumor, (c) activating the tumoricidal agent by heating the same within the tumor interstices above the melting point of the encapsulating resin so as to release the same within the tumor interstices without exposing the remaining normal body tissue to the effects of the agent.
Claim 2
Independent Claim
128 words
A method for treatment of tumors of animals and humans which comprises: (a) elevating the temperature of the tumor with exposure to a nonionizing radiofrequency field to partially necrose and attenuate its cells, (b) injecting intratumorally and extracellularly into the tumor interstices a therapeutic dose of a tumoricidal agent encapsulated with a polymeric coating of a biologically inert thermoplastic resin characterized as having a melting point higher than the temperature of the surrounding body tissue and within the elevated temperature range of the tumor, (c) activating the tumoricidal agent by heating the same within the tumor interstices above the melting point of the encapsulating resin so as to release the same within the tumor interstices without exposing the remaining normal body tissue to the effects of the agent.
Claim 3
Dependent Claim
26 words
A method according to claim 1 wherein the tumoricidal agent employed has an encapsulating thermoplastic polymer coating which melts within a temperature range of 40°-46° C.
Claim 4
Dependent Claim
29 words
A method according to claim 2 wherein the tumoricidal agent encapsulated is methotrexate and the encapsulating thermoplastic polymer is an acrylate resin having a melting point of 43° C.
Claim 5
Dependent Claim
15 words
A method according to claim 3 wherein the encapsulating thermoplastic polymer employed is polystearyl acrylate.
Claim 6
Independent Claim
117 words
A method for the administration of biologically active pharmaceuticals into a neoplasm of a mammal to reduce systemic side effects thereof which comprises: (a) introducing intratumorally and extracellularly into the interstices of the neoplasm within the segment of the mammal to be treated a therapeutic dose of microcapsules of a biologically active pharmaceutical which has been precoated with a releasable polymeric encapsulating resin coating which has a melting point range extending from 40°-46° C. and which until the coating is removed is substantially inert biologically, (b) removing this polymeric encapsulating resin coating from the pharmaceutical to release the active agent within the cellular interstices by radiofrequency heating the microcapsules above the melt temperature of the encapsulating resin.
Claim 7
Independent Claim
117 words
A method for the administration of biologically active pharmaceuticals into a neoplasm of a mammal to reduce systemic side effects thereof which comprises: (a) introducing intratumorally and extracellularly into the interstices of the neoplasm within the segment of the mammal to be treated a therapeutic dose of microcapsules of a biologically active pharmaceutical which has been precoated with a releasable polymeric encapsulating resin coating which has a melting point range extending from 40°-46° C. and which until the coating is removed is substantially inert biologically, (b) removing this polymeric encapsulating resin coating from the pharmaceutical to release the active agent within the cellular interstices by radiofrequency heating the microcapsules above the melt temperature of the encapsulating resin.
Claim 8
Dependent Claim
54 words
A method according to claim 5 wherein the heating is of a small organ or segment of the body capable of having its temperature elevated to a level of at least 40° C. for a period of time sufficient to elevate the temperature of the microcapsules above the melting point of their encapsulating resin.
Claim 9
Dependent Claim
27 words
A method according to claim 5 wherein the polymeric encapsulating resin coating removed is an acrylate polymer and the biologically active pharmaceutical is a cytotoxic cancericidal composition.
Claim 10
Independent Claim
91 words
A method for treatment of tumors of mammals which comprises: (a) preheating the tumor to be treated and elevating its temperature above body temperature, (b) administering a therapeutic dose of a tumoricidal agent encapsulated with a coating having a melting point higher than the temperature of the surrounding nontumor body tissue and within the elevated temperature range of the tumor into the interstices of the tumor and (c) activating the tumoricidal agent by heating the same within the tumor interstices to a temperature above the melting point of its encapsulated coating.
Claim 11
Independent Claim
91 words
A method for treatment of tumors of mammals which comprises: (a) preheating the tumor to be treated and elevating its temperature above body temperature, (b) administering a therapeutic dose of a tumoricidal agent encapsulated with a coating having a melting point higher than the temperature of the surrounding nontumor body tissue and within the elevated temperature range of the tumor into the interstices of the tumor and (c) activating the tumoricidal agent by heating the same within the tumor interstices to a temperature above the melting point of its encapsulated coating.
Claim 12
Independent Claim
122 words
A method for the administration of biologically active pharmaceuticals into a neoplasm of a mammal to reduce systemic side effects thereof which comprises: (a) introducing intratumorally and extarcellularly into the interstices of the neoplasm within the segment of the mammal to be treated a therapeutic dose of microcapsules of a biologically active pharmaceutical substrate which has been precoated with a releasable encapsulating coating of lauric acid or esters of lauric acid which have a melting point range extending from 40°-46° C. and which will until the coating is removed remain substantially inert biologically; (b) removing this coating from the pharmaceutical substrate to release the active agent within the interstices by radiofrequency heating of the microcapsules above the melt temperature of the coating.
Claim 13
Independent Claim
122 words
A method for the administration of biologically active pharmaceuticals into a neoplasm of a mammal to reduce systemic side effects thereof which comprises: (a) introducing intratumorally and extarcellularly into the interstices of the neoplasm within the segment of the mammal to be treated a therapeutic dose of microcapsules of a biologically active pharmaceutical substrate which has been precoated with a releasable encapsulating coating of lauric acid or esters of lauric acid which have a melting point range extending from 40°-46° C. and which will until the coating is removed remain substantially inert biologically; (b) removing this coating from the pharmaceutical substrate to release the active agent within the interstices by radiofrequency heating of the microcapsules above the melt temperature of the coating.
References Cited (Backward Citations)
US3991770A
Cited
US4106488A
Cited
US4269826A
Cited
US4359453A
Cited
US4337760A
Cited
US4345588A
Cited
US4323056A
Cited
US4331654A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1988-12-16 | 1989-06-17 | 1989-12-17 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1992-12-16 | 1993-06-17 | 1993-12-17 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1996-12-16 | 1997-06-17 | 1997-12-17 | $7700.00 | Window Closed / Lapsed |